EP2455374
Aðferð til að framleiða efnasambönd sem eru gagnleg sem hemlar SGLT
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
15.10.2009EP published:
16.12.2020EP application number:
12156035.3
EP translation filed:
20.1.2021Grant published:
15.2.2021EPO information:
European Patent Register
Max expiry date:
14.10.2029Expiry date:
14.10.2026Next due date:
31.10.2026
Title:
Process for the Preparation of Compounds useful as inhibitors of SGLT
Timeline
Today
15.10.2009EP application
16.12.2020EP Publication
20.1.2021Translation submitted
15.2.2021Registration published
14.10.2026Expires
Owner
Name:
Janssen Pharmaceutica N.V.Address:
Turnhoutseweg 30, 2340 Beerse, BE
Name:
Mitsubishi Tanabe Pharma CorporationAddress:
2-6-18, Kitahama Chuo-ku Osaka-shi, Osaka 541-8505, JP
Inventor
Name:
Filliers, Walter Ferdinand MariaAddress:
B-2340 Beerse, BE
Name:
Nieste, Patrick Hubert J.Address:
B-2340 Beerse, BE
Name:
Hatsuda, MasanoriAddress:
Osaka, 541-8505, JP
Name:
Yoshinaga, MasahikoAddress:
Osaka, 541-8505, JP
Name:
Yada, MitsuhiroAddress:
Osaka, 541-8505, JP
Name:
Teleha, ChristopherAddress:
Spring House, PA Pennsylvania 19477-0776, US
Name:
Broeckx, Rudy Laurent MariaAddress:
B-2340 Beerse, BE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
106260 PDate:
17.10.2008Country:
US
Number:
106231 PDate:
17.10.2008Country:
US
Number:
578934Date:
14.10.2009Country:
US
Classification
Categories:
C07D 309/10, C07H 7/04, C07H 13/04, C07C 1/00, C07D 333/12, C07D 409/10
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 7.9.2021
Expires: 14.10.2022
Payer: Árnason Faktor ehf.
Number: 14
Paid: 7.9.2022
Expires: 14.10.2023
Payer: Árnason Faktor ehf.
Number: 15
Paid: 13.10.2023
Expires: 14.10.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 17.9.2024
Expires: 14.10.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 8.10.2025
Expires: 14.10.2026
Payer: Árnason Faktor ehf.